EUVIMEDEUVIMED entdecken
Crossref

Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value

Piotr Łojko, Aldona Wierzbicka-Rucińska

Diagnostyka Laboratoryjna · 29.06.2026 · 62 (3) · 195-203

DOI: 10.5604/01.3001.0055.8710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostyka Laboratoryjna, erschienen am 29.06.2026. Verfasst von Piotr Łojko und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Myocardial injury is a frequent complication of COVID-19 and

is associated with worse clinical outcomes. While cardiac troponins have

been extensively studied, the clinical significance of creatine kinase (CK) and

creatine kinase–myocardial band (CK‑MB) in COVID‑19 remains less clearly

defined.

Aim

The aim of this systematic review was to critically evaluate the available

evidence regarding the diagnostic and prognostic significance of CK and CK-MB

in patients with COVID-19.

Materials and methods: A systematic review of the literature was conducted

in accordance with the PRISMA 2020 statement to evaluate the association

between CK‑related biomarkers and myocardial injury, disease severity, and

mortality in patients with COVID‑19. Due to the limited number of eligible

studies and heterogeneity in study design and outcome reporting, findings

were synthesized qualitatively.

Results

Four eligible studies evaluating CK and CK‑MB in hospitalized

COVID‑19 patients were identified. Across these studies, elevated CK or CK‑MB

levels were consistently associated with markers of myocardial injury and with

indicators of more severe disease. These biomarkers may therefore provide

additional information for risk stratification in COVID‑19.

Conclusions

CK and CK‑MB are widely available laboratory markers that

may assist in identifying myocardial injury and increased disease severity

in COVID‑19. Further prospective studies are required to clarify their prognostic

value and potential role in clinical decision‑making.

Zitieren

APA

Łojko, P., & Wierzbicka-Rucińska, A. (2026). Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value. Diagnostyka Laboratoryjna, 62(3), 195-203. https://doi.org/10.5604/01.3001.0055.8710

Vancouver

Łojko P, Wierzbicka-Rucińska A. Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value. Diagnostyka Laboratoryjna. 2026;62(3):195-203. doi:10.5604/01.3001.0055.8710

BibTeX
@article{ojko2026,
  author = {Łojko, Piotr and Wierzbicka-Rucińska, Aldona},
  title = {Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value},
  journal = {Diagnostyka Laboratoryjna},
  year = {2026},
  volume = {62},
  number = {3},
  pages = {195--203},
  doi = {10.5604/01.3001.0055.8710}
}
Kostenlos starten →